Graeme Clark Collection

Permanent URI for this collection

Search Results

Now showing 1 - 5 of 5
  • Item
    Thumbnail Image
    Speech perception in children using the advanced Speak speech-processing strategy
    Cowan, R. S. C. ; Brown, C. ; Whitford, L. A. ; Galvin, K. L. ; Sarant, J. Z. ; Barker, E. J. ; Shaw, S. ; King, A. ; Skok, M. ; Seligman, P. M. ; Dowell, R. C. ; Everingham, C. ; Gibson, W. P. R. ; Clark, Graeme M. ( 1995)
    The Speak speech-processing strategy, developed by the University of Melbourne and commercialized by Cochlear Pty Limited for use in the new Spectra 22 speech processor, has been shown to provide improved speech perception for adults in both quiet and noisy situations. The present study evaluated the ability of children experienced in the use of the Multipeak (Mpeak) speech-processing strategy (implemented in the Nucleus Minisystem-22 cochlear implant) to adapt to and benefit from the advanced Speak speech-processing strategy (implemented in the Nucleus Spectra 22 speech processor). Twelve children were assessed using Mpeak and Speak over a period of 8 months. All of the children had over 1 year's previous experience with Mpeak, and all were able to score significantly on open-set word and sentence tests using the cochlear implant alone. Children were assessed with both live-voice and recorded speech materials, including Consonant-Nucleus-Consonant monosyllabic words and Speech Intelligibility Test sentences. Assessments were made in both quiet and in noise. Assessments were made at 3-week intervals to investigate the ability of the children to adapt to the new speech-processing strategy. For most of the children, a significant advantage was evident when using the Speak strategy as compared with Mpeak. For 4 of the children, there was no decrement in speech perception scores immediately following fitting with Speak. Eight of the children showed a small (10% to 20%) decrement in speech perception scores for between 3 and 6 weeks following the changeover to Speak. After 24 weeks' experience with Speak, 11 of the children had shown a steady increase in speech perception scores, with final Speak scores higher than for Mpeak. Only 1 child showed a significant decrement in speech perception with Speak, which did not recover to original Mpeak levels.
  • Item
    Thumbnail Image
    Habilitation issues in the management of children using the cochlear multiple-channel cochlear prosthesis
    Cowan, Robert S. C. ; Barker, Elizabeth J. ; Dettman, Shani J. ; Blamey, Peter J. ; RANCE, GARY ; Sarant, Julia Z. ; Galvin, Karyn L. ; Dawson, Pam W. ; Hollow, Rod ; Dowell, Richard C. ; PYMAN, BRIAN ; Clark, Graeme M. (Wien, 1994)
    Since 1985, a significant proportion of patients seen in the Melbourne cochlear implant clinic have been children. The children represent a diverse population, with both congenital and acquired hearing-impairments, a wide-range of hearing levels pre-implant, and an age range from 2 years to 18 years. The habilitation programme developed for the overall group must be flexible enough to be tailored to the individual needs of each child, and to adapt to the changing needs of children as they progress. Long-term data shows that children are continuing to show improvements after 5-7 years of device use, particularly in their perception of open-set words and sentences. Habilitation programs must therefore be geared to the long-term needs of children and their families. Both speech perception and speech production need to be addressed in the specific content of the habilitation program for any individual child. In addition, for young children, the benefits of improved speech perception should have an impact on development of speech and language, and the focus of the programme for this age child will reflect this difference in emphasis. Specific materials and approaches will vary for very young children, school-age and teenage children. In addition, educational setting will have a bearing on the integration of listening and device use into the classroom environment.
  • Item
    Thumbnail Image
    Speech perception benefits for implanted children with preoperative residual hearing [Abstract]
    Hollow, R. ; Rance, G. ; Dowell, R.C. ; Pyman, B. ; Clark, Graeme M. ; Cowan, R. S. C. ; Galvin, K. L. ; Barker, E. J. ; Sarant, J. Z. ; Dettman, S. ( 1995)
    Since the implantation of the first children with the Nucleus 22-channel cochlear prosthesis in Melbourne in 1985, there has been rapid expansion in the number of implanted children world-wide. Improved surgical technique and experience in paediatric assessment and management have contributed to a trend to implant very young children. At the same time there has also been continuing development of improved speech processing strategies resulting in greater speech perception benefits. In the Melbourne program, over 60% of children obtain significant scores on open-set word and sentence tests using their cochlear implant alone without the aid of lipreading. As parents and professionals have become aware of these improved benefits to speech perception benefits in profoundly deaf children, there have been requests to consider implanting severely-to-profoundly deaf children. In these children with higher levels of residual hearing, only those children with poorer-than-expected performance on speech perception tests using hearing aids have been considered for surgery. A number of such cases have now been implanted in the Melbourne program. The speech perception benefits for this group are reported and are being compared with benefits for the profoundly deaf group of children.
  • Item
    Thumbnail Image
    Speech perception benefits for children using the Speak speech processing strategy in quiet and noise [Abstract]
    Whitford, L.A. ; Dowell, R.C. ; Brown, C. ; Gibson, W.P.R. ; Clark, Graeme M. ; Cowan, R. S. C. ; Galvin, K. L. ; Barker, E. J. ; Sarant, J. Z. ; Shaw, S. ; Everingham, C. ( 1995)
    The Speak speech processing strategy, based on the Spectral Maxima Speech Processor (SMSP) developed at the University of Melbourne, has now been implemented in the Spectra 22 speech processor developed by Cochlear Pty Limited, and clinical trials of both patients changing from the previous Multipeak strategy to Speak and patients starting up with. Speak have been conducted. Results in adult patients changing to Speak have shown significant improvements in speech perception in quiet and particularly in background noise as compared with Multipeak. Preliminary studies with children changing from Multipeak to Speak strategy, measured over a 10 month period, have also shown significant benefits from use of the Speak scheme in both quiet and noisy test situations. Results of follow up studies of these children after more than one year experience with the Speak processing strategy are presented. Statistical analysis of performance over time suggests that an increase in benefit is observed in children after additional experience with the Speak processing strategy. In addition, results for children who have used only the Speak processing strategy from the time of implantation are also presented. The results confirm that the Speak processing strategy provides significant benefits in quiet, and particularly in the presence of background noise for both groups of patients.
  • Item
    Thumbnail Image
    Speech perception benefits for children using an advanced cochlear implant speech processing strategy in quiet and in noise [Abstract]
    Dettman, Shani J. ; Skok, Marissa ; Dowell, Richard C. ; Clark, Graeme M. ; Cowan, Robert S. C. ; Whitford, Lesley A. ; Sarant, Julia Z. ; Galvin, Karyn L. ; Barker, Elizabeth J. ; King, Alison ( 1994)
    A new speech processing strategy (SPEAK) has been developed by the University of Melbourne and Cochlear Pty Ltd for use with the Nucleus 22-channel electrode array. In this strategy, 20 programmable filters are repetitively scanned at an average rate of 250Hz and the largest spectral components or maxima are selected from the incoming speech signal. This new speech processing strategy has been shown to provide significantly improved benefits in adult implant patients, particularly in the presence of background noise. This report presents data of a preliminary paediatric clinical trial of the new SPEAK speech processing strategy.